New dental material could save baby teeth without staining

NCT ID NCT04863222

Recruiting now Disease control Sponsor: Geisinger Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two dental materials, MTA and Biodentine, used to treat deep cavities in baby teeth. Researchers want to see which one works better and causes less tooth discoloration. The study involves 646 children aged 2 to 12 who need treatment on at least two baby molars. Participants will be followed for three years to check success rates and any signs of infection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Biodentine and mineral trioxide aggregate (MTA) are dental materials used to treat cavities in baby teeth.
What this could lead to: If Biodentine works as well as MTA, it could become a cheaper, non-staining option for treating cavities in children's baby teeth.
What could go wrong: This is a phase 4 study, so the materials are already in use. However, results may not apply to all children, and long-term success is still being checked.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DENTAL CARIES IN PRIMARY MOLARS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dental caries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INDIRECT PULP CAP PULPOTOMY

Contacts and locations

Locations

Geisinger
RECRUITING

Danville, Pennsylvania, 17822, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.